Share on StockTwits
 

Equities researchers at Cowen and Company boosted their target price on shares of athenahealth (NASDAQ:ATHN) from $88.00 to $123.00 in a research report issued on Friday, American Banking & Market News reports. Cowen and Company’s price objective indicates a potential downside of 29.28% from the stock’s previous close.

Shares of athenahealth (NASDAQ:ATHN) opened at 173.93 on Friday. athenahealth has a 52 week low of $82.01 and a 52 week high of $177.79. The stock’s 50-day moving average is $138.1 and its 200-day moving average is $124.. The company’s market cap is $6.464 billion.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.12. The company had revenue of $171.60 million for the quarter, compared to the consensus estimate of $168.39 million. During the same quarter last year, the company posted $0.29 earnings per share. athenahealth’s revenue was up 47.5% compared to the same quarter last year. On average, analysts predict that athenahealth will post $1.04 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on ATHN. Analysts at Zacks reiterated a “neutral” rating on shares of athenahealth in a research note to investors on Friday. They now have a $146.00 price target on the stock. Separately, analysts at Sterne Agee raised their price target on shares of athenahealth from $179.00 to $192.00 in a research note to investors on Friday. Finally, analysts at Raymond James upgraded shares of athenahealth from an “outperform” rating to a “strong-buy” rating in a research note to investors on Friday, December 13th. They now have a $150.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $143.80.

In other athenahealth news, SVP Daniel Orenstein unloaded 1,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $146.73, for a total value of $146,730.00. Following the completion of the transaction, the senior vice president now directly owns 31,262 shares of the company’s stock, valued at approximately $4,587,073. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.